Subscribe to receive the most important news
Japanese Health Minister Katsunobu Kato said that the Geladis Sciences anti-retroviral drug Remediver may be approved by Tokyo to treat Covid-19 patients when the review panel meets on Thursday.
Last week, the US Food and Drug Administration approved the emergency use of this drug to treat Covid-19, a highly contagious lung disease caused by the emerging corona virus.
And the company, “Gilead Sciences” applied for speedy approval of its use in Japan on Monday.
Kato said on a TV news program today, that if the review panel approves this drug, he intends to approve it immediately.
“Once it is imported, we would like it to be used by those suffering from serious conditions as soon as possible.”
On Monday, Prime Minister Shinzo Abe extended the state of emergency across the country until May 31, saying the incidence of the new Corona virus had not fallen enough to justify ending measures to slow the spread of the disease.
- The situation in Egypt